InsidersTradesSigma
Total declarations
Company
▲ Purchases (14 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
14
Disclosed sells
2
T+90 hit rate
29%
T+90 mean return
-13.8%
Across 14 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Korenko Michael K, Chief Executive Officer. Director active across 1 company, notably VIVOS INC. Cumulatively, 22 filings have been recorded. Breakdown: 14 buys · 2 sells. Total volume traded: €112k. History available since 7 June 2021. The latest transaction was disclosed on 28 October 2024 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations22 total
50,000 shares@ US$0.14163.0% of flowCommon StockSEC:0001415889-24-025674:0
Ideal exit: 25 Jul 2025 (T+270)
50,000 shares@ US$0.15913.2% of flowCommon StockSEC:0001415889-24-024085:0
Ideal exit: 27 Jun 2025 (T+270)
50,000 shares@ US$0.11192.3% of flowCommon StockSEC:0001415889-24-021126:0
Ideal exit: 10 May 2025 (T+270)
50,000 shares@ US$0.11762.4% of flowCommon StockSEC:0001415889-24-020862:0
Ideal exit: 4 May 2025 (T+270)
50,000 shares@ US$0.08721.8% of flowCommon StockSEC:0001415889-24-020572:0
Ideal exit: 28 Apr 2025 (T+270)
50,000 shares@ US$0.09352.0% of flowCommon StockSEC:0001415889-24-020244:0
Ideal exit: 25 Apr 2025 (T+270)
50,000 shares@ US$0.16873.5% of flowCommon StockSEC:0001415889-24-015308:0
Ideal exit: 1 Mar 2025 (T+270)
100,000 shares@ US$0.05172.2% of flowCommon StockSEC:0001415889-23-015057:0
Ideal exit: 9 Aug 2024 (T+270)
100,000 shares@ US$0.05362.3% of flowCommon StockSEC:0001415889-23-014424:0
Ideal exit: 14 Jul 2024 (T+270)
100,000 shares@ US$0.04662.0% of flowCommon StockSEC:0001415889-22-012603:0
Ideal exit: 11 Sept 2023 (T+270)
200,000 shares@ US$0.05174.5% of flowCommon StockSEC:0001415889-22-011531:0
Ideal exit: 14 Aug 2023 (T+270)
200,000 shares@ US$0.076.1% of flowCommon StockSEC:0001415889-22-008537:0
Ideal exit: 7 May 2023 (T+270)
76,250 sharesCommon StockSEC:0001415889-22-003417:0
22,266 sharesCommon StockSEC:0001415889-22-003199:0
130,000 shares@ US$0.0790.029% mcap6.4% of flowCommon StockSEC:0001415889-21-005797:0
Ideal exit: 4 Sept 2022 (T+270)
130,000 shares@ US$0.0794.1% of flowCommon StockSEC:0001415889-21-005797
Ideal exit: 4 Sept 2022 (T+270)
150,000 shares@ US$0.0450.018% mcap4.0% of flowCommon StockSEC:0001415889-21-004721:0
150,000 shares@ US$0.0452.6% of flowCommon StockSEC:0001415889-21-004721
89,689 shares@ US$0.100.024% mcap5.3% of flowCommon StockSEC:0001415889-21-003838:0
89,689 shares@ US$0.103.4% of flowCommon StockSEC:0001415889-21-003838
2,500,000 shares@ US$0.0240.15% mcap34.3% of flowCommon StockSEC:0001415889-21-002889:0
2,500,000 shares@ US$0.02422.2% of flowCommon StockSEC:0001415889-21-002889
22 of 22 declarations
About Korenko Michael K
Korenko Michael K serves as CEO and President at VIVOS INC. He is responsible for the strategic direction of the company and overseeing operations. His role is essential in ensuring the growth and performance of the company in the healthcare sector.
